NASUS PHARMA LTD
Q1 2026 13F Holders
Symbol
NSRX
CUSIP
M7071P109
Type
Equity
Class
ORD SHS
Num filings
9
Total reported value, excl. options
$4.83 M
Compare 2026 Q1 to
2026 Q2
2025 Q4
2025 Q3
Manager
Report Date
Value ($000)
Shares
Option Type